Literature DB >> 8881826

Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.

R Jalan1, J Sargentoni, G A Coutts, J D Bell, K Rolles, A K Burroughs, S D Taylor Robinson.   

Abstract

BACKGROUND: In vivo hepatic phosphorus-31 magnetic resonance spectroscopy (31P MRS) provides biochemical information about phosphorus metabolism. AIM: To assess 31P MRS as a prognostic marker in patients with primary biliary cirrhosis (PBC) in relation to the current clinical prognostic models. PATIENTS AND METHODS: Twenty three patients with PBC of varying functional severity and 16 matched healthy volunteers were studied using in vivo 31P MRS. Spectra were acquired using a 1.5 T spectroscopy system. Peak area ratios of phosphomonoesters (PME), inorganic phosphate (Pi), and phosphodiesters (PDE) and nucleotide triphosphate (NTP) were calculated. Pugh score, Christensen prognostic index, and R value according to the Mayo model were calculated from the clinical data.
RESULTS: The PME/NTP, Pi/NTP, PME/PDE, and PME/Pi ratios and the PME signal height ratio (SHR) were significantly higher, while the PDE/NTP and PDE/SHR were significantly lower in PBC patients compared with healthy volunteers (p < 0.01). Significant correlations were seen between PME/Pi ratio and the prognostic index according to Christensen (r = 0.63, p < 0.001), R value according to the Mayo model (r = 0.45, p < 0.03), and with the Pugh score (r = 0.55, p < 0.007).
CONCLUSIONS: This study shows that PME/Pi ratio obtained from 31P MRS correlates well with all three of the commonly used models of prognosis in patients with PBC. A longitudinal study with larger number of patients is required to confirm these findings and elucidate the biochemical changes underlying this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881826      PMCID: PMC1383248          DOI: 10.1136/gut.39.1.141

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage.

Authors:  A Nyberg; A Engström-Laurent; L Lööf
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

2.  The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis.

Authors:  S Eriksson; O Zettervall
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

4.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.

Authors:  D J Taylor; P J Bore; P Styles; D G Gadian; G K Radda
Journal:  Mol Biol Med       Date:  1983-07

5.  Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history.

Authors:  D R Beswick; G Klatskin; J L Boyer
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

6.  Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.

Authors:  E Christensen; J Neuberger; J Crowe; D G Altman; H Popper; B Portmann; D Doniach; L Ranek; N Tygstrup; R Williams
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

7.  Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study.

Authors:  S D Taylor-Robinson; E L Thomas; J Sargentoni; C D Marcus; B R Davidson; J D Bell
Journal:  Biochim Biophys Acta       Date:  1995-10-17

8.  NIH conference: Primary biliary cirrhosis: a model autoimmune disease.

Authors:  S P James; J H Hoofnagle; W Strober; E A Jones
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Prognostic value of the aminopyrine breath test in cirrhotic patients.

Authors:  J P Villeneuve; C Infante-Rivard; M Ampelas; G Pomier-Layrargues; P M Huet; D Marleau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

10.  The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.

Authors:  A L Baker; P S Krager; A N Kotake; D A Schoeller
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

View more
  12 in total

1.  In vivo electron spin resonance spectroscopy: what use is it to gastroenterologists?

Authors:  N S Dhanjal; I J Cox; S D Taylor-Robinson
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 2.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy.

Authors:  Bhavana S Solanky; Gina J Sanchez-Canon; Jeremy F L Cobbold; Simon D Taylor-Robinson; Jimmy D Bell; Cheryl L Scudamore; Eleanor Ross; Julie C Holder; Po-Wah So; I Jane Cox
Journal:  Toxicol Sci       Date:  2012-01-18       Impact factor: 4.849

4.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.

Authors:  R Müllenbach; A Bennett; N Tetlow; N Patel; G Hamilton; F Cheng; J Chambers; R Howard; S D Taylor-Robinson; C Williamson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

7.  Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy.

Authors:  Antti Hakkarainen; Jesper Lundbom; Esa K Tuominen; Marja-Riitta Taskinen; Kirsi H Pietiläinen; Nina Lundbom
Journal:  MAGMA       Date:  2014-06-04       Impact factor: 2.310

8.  Magnetic resonance imaging and spectroscopy for differential assessment of liver abnormalities induced by Opisthorchis felineus in an animal model.

Authors:  Alexandra G Pershina; Vladimir V Ivanov; Lina V Efimova; Oleg B Shevelev; Sergey V Vtorushin; Tatjana V Perevozchikova; Alexey E Sazonov; Ludmila M Ogorodova
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

9.  In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.

Authors:  S D Taylor-Robinson; J Sargentoni; J D Bell; E L Thomas; C D Marcus; K K Changani; N Saeed; H J Hodgson; B R Davidson; A K Burroughs; K Rolles; C S Foster; I J Cox
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.

Authors:  Adil Bashir; Robert Gropler; Joseph Ackerman
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.